Answers are grounded in this paper and cite their sources.
RICTOR, a core component of mTORC2, regulates cell survival, proliferation, and cytoskeletal organization. To dissect its role in epithelial cell biology, we generated ten clonal HEK-293T lines with frameshift deletions in the RICTOR gene using paired sgRNAs targeting exon 3. sgRNA efficiency was assessed by TIDE and T7E1 assays, and the two best sgRNAs were selected for deletion induction. Overall, 10 clonal lines with composite deletion were isolated. Complete loss of RICTOR mRNA in these clones was verified by RT-qPCR. Targeted qRT-PCR profiling revealed a consistent molecular signature: downregulation of some mTORC2-associated genes, compensatory upregulation of mTORC1 components (RPTOR, PRAS40) and PRR5, and increased ERK1/2 mRNA and, in most clones, increased ERK1/2 protein and p-ERK2. Proliferation was significantly slowed (doubling time increased nearly 50%, from 30 to 47 h). Scratch-wound assays demonstrated markedly reduced migration. Notably, RICTOR-KO cells formed compact multicellular aggregates instead of a dispersed monolayer, accompanied by upregulation of adhesion genes (CDH1, FLNA, FN1, ITGA5) and downregulation of epithelial–mesenchymal transition (EMT) markers (VIM, SNAI1, ZEB1). Our results establish HEK-293T RICTOR-KO as a valuable model to study mTORC2-dependent regulation of adhesion and migration, and highlight the interplay between mTOR and MAPK signaling in maintaining epithelial homeostasis. Potential therapeutic use of RICTOR-KO as an inhibitor of malignancy of solid tumors deserves further investigation.
No takes yet. Share an insight, caveat, or question.
Marukhina et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: